EASL Liver Cancer Summit 2025
The EASL Liver Cancer Summit 2025 has come to a close. We want to express our heartfelt gratitude to our delegates, faculty, organisers, and sponsors for your active engagement and enthusiasm throughout this extraordinary event! The EASL Liver Cancer Summit…
Personalised medicine in hepatobiliary malignancies
After years of stagnation, a paradigm shift has occurred in the therapy of hepatobiliary malignancies: immune-oncology based combinations and new options in the second line revolutionized the treatment of patients with hepatocellular carcinoma, while biliary cancers - endowed with a…
EASL Liver Cancer Summit 2024
Over three inspiring days in Rotterdam and online, we explored the latest in liver cancer care, from new research on primary liver tumours to innovative treatment strategies. If you have attended the meeting, you can claim 12.5 CME credits. All…
